Abstract:Patient-derived cancer cells (PDCs) and patient-derived xenografts (PDXs) are often used as tumor models, but have many shortcomings. PDCs not only lack diversity in terms of cell type, spatial organization, and microenvironment but also have adverse effects in stem cell cultures, whereas PDX are expensive with a low transplantation success rate and require a long culture time. In recent years, advances in three-dimensional (3D) organoid culture technology have led to the development of novel physiological systems that model the tissues of origin more precisely than traditional culture methods. Patient-derived cancer organoids bridge the conventional gaps in PDC and PDX models and closely reflect the pathophysiological features of natural tumorigenesis and metastasis, and have led to new patient-specific drug screening techniques, development of individualized treatment regimens, and discovery of prognostic biomarkers and mechanisms of resistance. Synergistic combinations of cancer organoids with other technologies, for example, organ-on-a-chip, 3D bio-printing, and CRISPR-Cas9-mediated homology-independent organoid transgenesis, and with treatments, such as immunotherapy, have been useful in overcoming their limitations and led to the development of more suitable model systems that recapitulate the complex stroma of cancer, inter-organ and intra-organ communications, and potentially multiorgan metastasis. In this review, we discuss various methods for the creation of organ-specific cancer organoids and summarize organ-specific advances and applications, synergistic technologies, and treatments as well as current limitations and future prospects for cancer organoids. Further advances will bring this novel 3D organoid culture technique closer to clinical practice in the future.

Organoid models of the tumor microenvironment and their applications

Organoids: new frontiers in tumor immune microenvironment research

Tumor organoids: applications in cancer modeling and potentials in precision medicine

Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold

Organoids for Cancer Research: Advances and Challenges

Organoids: approaches and utility in cancer research

Organoid Models of Tumor Immunology

Organoid technology and applications in cancer research

Tumor organoids: From inception to future in cancer research

Construction of tumor organoids and their application to cancer research and therapy

Flourishing tumor organoids: History, emerging technology, and application

3D Tumor Spheroid and Organoid to Model Tumor Microenvironment for Cancer Immunotherapy

Organoid co-culture models of the tumor microenvironment promote precision medicine

Organoid and Spheroid Tumor Models: Techniques and Applications

Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment

Cancer organoids: A platform in basic and translational research

Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy

Organoid Models for Precision Cancer Immunotherapy

Organoids: opportunities and challenges of cancer therapy

Cancer organoid co-culture model system: Novel approach to guide precision medicine

Advancing cancer research through organoid technology